×
About 7,805 results

ALLMedicine™ Diphtheria Center

Research & Reviews  2,277 results

T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT05200559

Aug 5th, 2022 - Immunotherapy with immune checkpoint inhibitors (ICI) has emerged as a promising option in several solid tumors, given its durable response and low toxicities. However, the durable benefit of ICI as monotherapy is limited to certain cancers like m...

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary...
https://clinicaltrials.gov/ct2/show/NCT04300192

Aug 4th, 2022 - Study duration per participant will be approximately 30 days including: 1 day of screening and vaccination, a phone call and a safety follow-up/end of study visit, at Day 8 and Day 30 after vaccine administration, respectively.

Obstetric Provider Attitudes and Office Practices for Maternal Influenza and Tdap Vacci...
https://doi.org/10.1089/jwh.2022.0030
Journal of Women's Health (2002); Rand CM, Bender R et. al.

Jul 30th, 2022 - Background: Although maternal vaccination with influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines improve health outcomes for pregnant individuals and infants, maternal vaccination rates are low. This ...

Antibody waning after immunosuppressive chemotherapy and immunomodulators, re-immunizat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335959
BMC Infectious Diseases; Abdolkarimi B, Amanati A et. al.

Jul 29th, 2022 - Immunosuppressive chemotherapy increase the risk of vaccine-preventable infectious diseases in children; nevertheless, chemotherapy may result in delay or miss updated immunization schedules. The predictable antibody waning after incomplete primar...

Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
https://clinicaltrials.gov/ct2/show/NCT05480462

Jul 29th, 2022 - A single blind, randomized, comparative, multicentre clinical trial of the immunogenicity and safety of booster immunization with bivalent vaccine against tetanus and diphtheria CLODIVAC (IBSS BIOMED S.A.) and Td-Impfstoff Mérieux (Sanofi Pasteur)...

see more →

Guidelines  13 results

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Upd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367039
MMWR. Morbidity and Mortality Weekly Report; Havers FP, Moro PL et. al.

Jan 24th, 2020 - Since 2005, a single dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine has been recommended by the Advisory Committee on Immunization Practices (ACIP) for adolescents and adults (1,2). After receipt of Tdap,...

ACOG Committee Opinion No. 741 Summary: Maternal Immunization.
https://doi.org/10.1097/AOG.0000000000002665
Obstetrics and Gynecology;

May 26th, 2018 - Immunization is an essential part of care for adults, including pregnant women. Influenza vaccination for pregnant women is especially important because pregnant women who contract influenza are at greater risk of maternal morbidity and mortality ...

Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600
MMWR. Recommendations and Reports : Morbidity and Mortali... Liang JL, Tiwari T et. al.

Apr 28th, 2018 - This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previ...

Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, a...
https://doi.org/10.1097/AOG.0000000000002301
Obstetrics and Gynecology;

Aug 24th, 2017 - The overwhelming majority of morbidity and mortality attributable to pertussis infection occurs in infants who are 3 months and younger. Infants do not begin their own vaccine series against pertussis until approximately 2 months of age. This leav...

see more →

Drugs  71 results see all →

Clinicaltrials.gov  233 results

T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT05200559

Aug 5th, 2022 - Immunotherapy with immune checkpoint inhibitors (ICI) has emerged as a promising option in several solid tumors, given its durable response and low toxicities. However, the durable benefit of ICI as monotherapy is limited to certain cancers like m...

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary...
https://clinicaltrials.gov/ct2/show/NCT04300192

Aug 4th, 2022 - Study duration per participant will be approximately 30 days including: 1 day of screening and vaccination, a phone call and a safety follow-up/end of study visit, at Day 8 and Day 30 after vaccine administration, respectively.

Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
https://clinicaltrials.gov/ct2/show/NCT05480462

Jul 29th, 2022 - A single blind, randomized, comparative, multicentre clinical trial of the immunogenicity and safety of booster immunization with bivalent vaccine against tetanus and diphtheria CLODIVAC (IBSS BIOMED S.A.) and Td-Impfstoff Mérieux (Sanofi Pasteur)...

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
https://clinicaltrials.gov/ct2/show/NCT05476770

Jul 27th, 2022 - Tagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin redirected to target CD123 has been approved for treatment in pediatric and adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). This trial aims to exami...

Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh
https://clinicaltrials.gov/ct2/show/NCT05475379

Jul 26th, 2022 - A double blinded, randomized-controlled, non-inferiority trial of a typhoid conjugate vaccine, Typhocon (Vi- polysaccharide conjugated to diphtheria toxoid, Vi-DT), manufactured by a local company, Incepta Vaccine Limited will be conducted. The va...

see more →

News  518 results

Pandemic Behind 'largest Backslide in Childhood Vaccination in a Generation': UN
https://www.medscape.com/viewarticle/977244

Jul 18th, 2022 - LONDON (Reuters) - Around 25 million children around the world missed out on routine vaccinations last year that protect against life-threatening diseases, as the knock-on effects of the pandemic continue to disrupt health care globally. That is t...

Pandemic Behind 'Largest Backslide in Childhood Vaccination in a Generation': UN
https://www.medscape.com/viewarticle/977255

Jul 15th, 2022 - LONDON (Reuters) - Around 25 million children around the world missed out on routine vaccinations last year that protect against life-threatening diseases, as the knock-on effects of the pandemic continue to disrupt health care globally. That is t...

Will the US Overcome Its COVID Complacency Even as the Threat Returns?
https://www.medscape.com/viewarticle/975648

Jun 15th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A few months ago, it seemed as though the country was poised to finally tame the pandemic, after two years of restrictions and tens of billions in...

Antibiotics use and vaccine antibody levels
https://www.mdedge.com/pediatrics/article/253722/vaccines/antibiotics-use-and-vaccine-antibody-levels
Michael E. Pichichero, MD

May 1st, 2022 - In this column I have previously discussed the microbiome and its importance to health, especially as it relates to infections in children. Given the appreciated connection between microbiome and immunity, my group in Rochester, N.

Routine Childhood Vaccinations Dropped 1% During Pandemic
https://www.medscape.com/viewarticle/972624

Apr 22nd, 2022 - The vaccination rate among kindergartners fell to around 94% during the 2020-21 school year, a drop of about 1% from the previous school year, the CDC said Thursday. Nationally, 93.9% of children received two doses of measles, mumps, and rubella v...

see more →

Patient Education  10 results see all →